Advisory: Alert incorrectly tagged to Curis Inc withdrawn
12/01/2026 18:18
An alert on Danish drugmaker Curasight A/S CURAS.TE announcing preliminary data from the phase 1 trial for its drug, uTREAT, was inadvertently tagged to U.S.-based Curis Inc CRIS.O, an unrelated entity, and has been withdrawn. There will be no substitute. STORY_NUMBER: nTUA4WDPQN STORY_DATE: January 12, 2026 STORY_TIME: 06:03 PM GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Curis
See all newsCuris Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Curis Announces Pricing Of $5.6 Million Public Offering
Curis Inc expected to post a loss of $7.84 a share - Earnings Preview
Curis Inc expected to post a loss of $7.47 a share - Earnings Preview
Brief: Curis Doses First Five Patients In Takeaim Cll Study